# Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients

> **NCT02566265** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 122 (actual)

## Conditions studied

- Influenza
- Multiple Myeloma
- Waldenstrom's Macroglobulinemia
- Plasma Cell Disorders
- MGUS

## Interventions

- **BIOLOGICAL:** Fluzone High Dose Vaccine
- **BIOLOGICAL:** Standard of care/Placebo

## Key facts

- **NCT ID:** NCT02566265
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-10
- **Final completion:** 2018-06
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02566265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02566265, "Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02566265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*